Lincare
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Growth Equity VC | ||
N/A | N/A | IPO | |
$4.6b Valuation: $4.6b | Acquisition | ||
Total Funding | - |
Related Content
Recent News about Lincare
EditLincare is a leading provider of respiratory care services and durable medical equipment, primarily serving patients with chronic respiratory conditions. Operating in the healthcare market, Lincare offers a range of products and services including disease progression management, high-frequency chest wall oscillation (HFCWO), home INR testing, enteral therapy, and powered mobility solutions. The company serves a diverse clientele, including Medicare beneficiaries and individuals requiring long-term care. Lincare's business model focuses on delivering high-quality, in-home healthcare solutions that improve patient outcomes and quality of life. Revenue is generated through the sale and rental of medical equipment, as well as through service fees for disease management programs and other healthcare services.
Keywords: respiratory care, durable medical equipment, disease management, HFCWO, home INR testing, enteral therapy, powered mobility, chronic conditions, Medicare, long-term care.